Showing results (151-160 of 185) with videos related to

Sort By:
Pageof 19
Journal of Hepatology|February 14, 2017
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinomaGiuseppe Cabibbo, Salvatore Petta, Marco Barbara, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2020
The changing scenario of hepatocellular carcinoma in Italy: an updateFrancesca Garuti, Andrea Neri, Francesca Avanzato, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|July 29, 2022
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitorsBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Frontiers in Medicine|June 12, 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter studyOliviero Riggio, Ciro Celsa, Vincenza Calvaruso, et al.
Viruses|May 25, 2024
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV)Maria Giovanna Quaranta, Luisa Cavalletto, Francesco Paolo Russo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 12, 2020
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational studyAlessio Aghemo, Alfredo Alberti, Pietro Andreone, et al.
JHEP Reports : Innovation in Hepatology|July 31, 2023
Landscape of alcohol-related hepatocellular carcinoma in the last 15 years highlights the need to expand surveillance programsNicola Reggidori, Laura Bucci, Valentina Santi, et al.
Gut|December 22, 2021
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA databaseAlessandro Vitale, Gianluca Svegliati-Baroni, Alessio Ortolani, et al.
Digestive Diseases and Sciences|May 3, 2025
Characteristics and Outcomes of Hepatocellular Carcinoma in Patients with Autoimmune HepatitisAndrea Pasta, Giulia Pieri, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 23, 2020
Comparison of prognostic models in advanced hepatocellular carcinoma patients undergoing Sorafenib: A multicenter studyGiovanni Marasco, Antonio Colecchia, Maria Letizia Bacchi Reggiani, et al.
Pageof 19